Rate My Professor Brian Dale

Dr. Brian Dale is an Adjunct Senior Lecturer in the School of Pharmacy and Biomedical Sciences within the College of Health at Adelaide University. He earned a PhD in Medicine from the University of Western Australia and is a Fellow of the Australian Institute of Medical and Clinical Scientists (AIMS). Before entering academia full-time, Dale accumulated extensive practical experience as a medical laboratory scientist in haematology, transfusion medicine, and haemostasis, including senior scientist and managerial positions. Currently, he coordinates haematology and clinical practice courses in the Laboratory Medicine Program and serves as a member of the AIMS Program Accreditation Council, where he contributes to the accreditation of Laboratory Medicine programs throughout Australia. He is eligible to supervise Masters and PhD students and currently acts as principal supervisor for a doctoral candidate researching the role of platelet-derived microparticles and mitochondria in myeloproliferative neoplasms.

Dale's research centers on identifying factors contributing to thrombosis in haematological cancer, with specializations encompassing haematological malignancy and thrombosis, platelet microparticle activity, thrombin generation assays for haemostasis evaluation, global haemostasis tests, novel diagnostic tests and therapies, thrombosis and bleeding disorders, fibrin clot stability, and heparin-induced thrombocytopenia. His scholarly output includes numerous peer-reviewed articles, such as Ross et al. (2023) 'Platelets from patients with myeloproliferative neoplasms have increased numbers of mitochondria that are hypersensitive to depolarization by thrombin' in Scientific Reports; Martini et al. (2021) 'CD36 promotes vasculogenic mimicry in melanoma by mediating adhesion to the extracellular matrix' in BMC Cancer; Martini et al. (2020) 'Platelets disrupt vasculogenic mimicry by cancer cells' in Scientific Reports; Dale et al. (2016) 'Laboratory measurement of the direct oral anticoagulants' in British Journal of Haematology; and Dale et al. (2014) 'Comparison of the effects of apixaban and rivaroxaban on prothrombin and activated partial thromboplastin times using various reagents' in Journal of Thrombosis and Haemostasis. Additionally, he co-authored book chapters on haematological system structure and function, and alterations across the life span, in Understanding Pathophysiology - ANZ adaptation (2011), as well as conference contributions on platelet receptors and student supplements for haematology.